Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,387Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M5,387EPS $--Operating Margin %-570.3Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.4PEG1.3ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M15.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IBB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
IBBJohn Keeley 2014-12-31 Buy 0.01%$255.27 - $308.01
$ 364.5429%New holding905
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IBB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

IBB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bunka, ChristopherDirector, Senior Officer 2015-05-22Buy20,000$0.18202422.22view
Bunka, ChristopherDirector, Senior Officer 2015-05-22Buy10,000$0.17214335.29view
Bunka, ChristopherDirector, Senior Officer 2015-05-22Buy10,000$0.17214335.29view
Pommier, PaulDirector 2015-05-22Buy4,700$1.3826315.94view
Pommier, PaulDirector 2015-05-22Buy20,300$1.425938.57view
Smith, MarkDirector, Senior Officer 2015-05-22Buy5,000$0.6555983.08view
MERCER, JOHN WILLIAMDirector, Senior Officer 2015-05-22Buy100,000$0.07520671.43view
Aggarwal, SalilSenior Officer 2015-05-22Sell10,000$1.6422128.05view
Wilson, JamesDirector or Senior Officer of 10% Security Holder 2015-05-22Buy6,700$8.154372.88view
Shareck, AndrDirector 2015-05-22Buy200,000$0.031215033.33view

Press Releases about IBB :

    Quarterly/Annual Reports about IBB:

      News about IBB:

      Articles On GuruFocus.com

      More From Other Websites
      What You Need To Know About This Higher Risk Stage Of The Bull Market May 23 2015
      Are Large Caps the Go-To Stocks Yet? May 22 2015
      Esperion Therapeutics: 15 Reasons to Take Profits May 22 2015
      Your first trade for Friday May 21 2015
      Biotech: Don't Bet Against Small Caps Just Yet May 21 2015
      Why Do Biotech Stocks Look Attractive? May 21 2015
      Buy America? Here’s some fuel for the contrarian fire May 21 2015
      Will Healthcare and Biotech Propel Stocks Higher? May 19 2015
      Biotech stock crashes 70% after a failed drug trial May 18 2015
      Biotech movers: JNJ & BLUE May 15 2015
      Why You Should Move Out of Momentum Stocks May 15 2015
      Cancer data deluge May 14 2015
      Adding a Factor Fund Gives You Tactical Exposure May 14 2015
      Biotech goldmine May 13 2015
      This biotech stock is a bargain: Strategist May 13 2015
      FDA panel approves Vertex drug May 12 2015
      ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary May 11 2015
      Yellen's worried-is that a good thing for markets? May 09 2015
      Pisani: Markets shrug at big week of biotech IPOs May 07 2015
      Is biotech in a bubble? May 07 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)